Sanofi SA Sponsored ADRSanofi SA Sponsored ADRSanofi SA Sponsored ADR

Sanofi SA Sponsored ADR

No trades
See on Supercharts

Key facts today


Berenberg analysts noted Sanofi's adjusted profitability improved due to an accounting change, raising the 2024 operating margin estimate to 33%. Shares fell by 1.4% after the news.
Sanofi plans to invest at least $20 billion in the U.S. through 2030 to enhance its manufacturing and research capabilities.
Analyze the impactAnalyze the impact
Market capitalization
‪123.99 B‬USD
4.02USD
‪6.01 B‬USD
‪44.44 B‬USD
‪2.43 B‬
Beta (1Y)
0.52

About Sanofi SA


CEO
Paul Hudson
Website
Headquarters
Paris
Founded
1994
ISIN
US80105N1054
FIGI
BBG000BBD5N1
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Check out other big names from the same industry as SNY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US801060AD6
Sanofi SA 3.625% 19-JUN-2028
Yield to maturity
3.92%
Maturity date
Jun 19, 2028
FR1332437
Sanofi SA 1.875% 21-MAR-2038
Yield to maturity
3.52%
Maturity date
Mar 21, 2038
FR1340985
Sanofi 1.25% 21-MAR-2034
Yield to maturity
3.18%
Maturity date
Mar 21, 2034
FR14010MR
Sanofi SA 3.0% 23-JUN-2032
Yield to maturity
3.00%
Maturity date
Jun 23, 2032
FR1400Y1I
Sanofi SA 2.75% 11-MAR-2031
Yield to maturity
2.88%
Maturity date
Mar 11, 2031
FR1332435
Sanofi SA 1.375% 21-MAR-2030
Yield to maturity
2.70%
Maturity date
Mar 21, 2030
FR1350511
Sanofi 1.5% 01-APR-2030
Yield to maturity
2.69%
Maturity date
Apr 1, 2030
FR1340984
Sanofi 0.875% 21-MAR-2029
Yield to maturity
2.59%
Maturity date
Mar 21, 2029
FR14010MQ
Sanofi SA 2.625% 23-JUN-2029
Yield to maturity
2.59%
Maturity date
Jun 23, 2029
FR1314400
Sanofi 1.125% 05-APR-2028
Yield to maturity
2.36%
Maturity date
Apr 5, 2028
FR1320163
Sanofi 0.5% 13-JAN-2027
Yield to maturity
2.26%
Maturity date
Jan 13, 2027

See all SNY bonds 

PVAL
Putnam Focused Large Cap Value ETF
Weight
1.72%
Market value
‪72.26 M‬
USD
FVD
First Trust Value Line Dividend Index Fund
Weight
0.44%
Market value
‪39.90 M‬
USD
PPH
VanEck Pharmaceutical ETF
Weight
4.54%
Market value
‪32.00 M‬
USD
PID
Invesco International Dividend Achievers ETF
Weight
3.04%
Market value
‪26.58 M‬
USD
AVDE
Avantis International Equity ETF
Weight
0.23%
Market value
‪22.11 M‬
USD
FENI
Fidelity Enhanced International ETF
Weight
0.30%
Market value
‪13.34 M‬
USD
LIFE
Evolve Global Healthcare Enhanced Yield Fund
Weight
4.99%
Market value
‪10.44 M‬
USD
LIFE.B
Evolve Global Healthcare Enhanced Yield Fund
Weight
4.99%
Market value
‪10.44 M‬
USD
BDYN
iShares Dynamic Equity Active ETF
Weight
0.45%
Market value
‪9.45 M‬
USD
B
BASV
Brown Advisory Sustainable Value ETF
Weight
4.36%
Market value
‪8.54 M‬
USD

Explore more ETFs